Wu, X., Li, Y., Chen, J., Chen, J., Zhang, W., Lu, X., . . . Bu, H. Multimodal recurrence risk prediction model for HR+/HER2- early breast cancer following adjuvant chemo-endocrine therapy: Integrating pathology image and clinicalpathological features. BMC.
Chicago Style (17th ed.) CitationWu, Xiaoyan, et al. Multimodal Recurrence Risk Prediction Model for HR+/HER2- Early Breast Cancer Following Adjuvant Chemo-endocrine Therapy: Integrating Pathology Image and Clinicalpathological Features. BMC.
MLA (9th ed.) CitationWu, Xiaoyan, et al. Multimodal Recurrence Risk Prediction Model for HR+/HER2- Early Breast Cancer Following Adjuvant Chemo-endocrine Therapy: Integrating Pathology Image and Clinicalpathological Features. BMC.
Warning: These citations may not always be 100% accurate.